NewG Lab Changes Name to NewG Lab Pharma to Leap Forward as a Comprehensive Pharmaceutical Company

[Asia Economy Reporter Yoo Hyun-seok] Newgelab has changed its company name to Newgelab Pharma and is intensifying its bio business, which it has been promoting as a new growth engine, as a core business.

Newgelab announced on the 29th that it changed its company name from Newgelab to Newgelab Pharma at the regular shareholders' meeting. This name change is interpreted as an effort to prominently highlight Newgelab's bio business division.

A Newgelab official said, "Through the name change, Newgelab is declaring externally that it is pursuing full-scale growth as a comprehensive pharmaceutical company," and added, "Based on the various pipelines secured so far, we expect to be able to communicate the company's vision of 'contributing to human health and happiness through new drug development.'"

Newgelab is developing various new drugs including the anticancer agent KAT (Ko Anticancer Technology), oral COVID-19 treatments, and drugs for non-small cell lung cancer. Recently, following the acquisition of Hanwool TL, a bio cold chain specialist company, it succeeded in acquiring Arije Pharm, completing the pharmaceutical industry value chain encompassing new drug development, production, sales, and transportation, and is ready to leap forward as a comprehensive pharmaceutical company.

Meanwhile, Arije Pharm also changed its company name to 'Newgelab Pharm' through a shareholders' meeting, and synergy among Newgelab's bio business affiliates is expected to accelerate.

This content was produced with the assistance of AI translation services.